Control group# | COPD group¶ | ||||
Baseline | p-value+ | Baseline | Follow-up | p-value§ | |
Treadmill testing | |||||
V′O2,peak mL·kg−1·min−1 | 38.9±5.0 | 0.005 | 20.4±4.0 | 20.2±3.6** | 0.68 |
WE mL·kg−1·min−1 | ND | 11.0±0.6 | 10.6±0.5 | 0.44 | |
V′E at peak work L·min−1 | 87±8 | 0.001 | 49±9 | 49±11*** | 0.87 |
Knee-extensor testing | |||||
Peak work W | 23.2±6.7 | 0.03 | 14.6±4.9 | 20.0±5.3 | 0.001 |
Quadriceps muscle mass kg | 1.64±0.20 | 0.10 | 1.39±0.27 | 1.43±0.26 | 0.45 |
Femoral blood flow at 6 Watts L·min−1 | 1185±236 | 0.85 | 1213±242 | 1195±250 | 0.87 |
Femoral blood flow at peak work L·min−1 | 2854±168 | 0.03 | 2127±655 | 2631±348 | 0.03 |
Muscle V′O2 at 6 Watts mL·kg−1·min−1 | ND | 117±30 | 104±29 | 0.26 | |
Muscle V′O2 at peak work mL·kg−1·min−1 | ND | 200±40 | 248±43 | 0.048 | |
Pulmonary V′O2 at 6 Watts mL·kg−1·min−1 | 5.21±1.21 | 0.07 | 7.81±2.67 | 5.78±1.29 | 0.026 |
Pulmonary V′O2 at peak work mL·kg−1·min−1 | 14.6±4.9 | 0.036 | 10.9±1.8 | 11.7±1.2 | 0.30 |
Lactate at 6 Watts mmol·L−1 | ND | 2.16±1.02 | 1.67±1.13 | 0.17 | |
Lactate at peak work mmol·L−1 | ND | 4.4±2.2 | 6.3±2.3 | 0.06 | |
V′E at 6 Watts L·min−1 | 13.0±1.2 | 0.02 | 16.7±2.7 | 13.3±2.0 | 0.007 |
V′E at peak work L·min−1 | 33.9±9.9 | 0.16 | 27.4±4.3 | 29.3±2.8 | 0.18 |
Data are presented as mean±sd, unless otherwise stated. COPD: chronic obstructive pulmonary disease; V′O2,peak: peak oxygen consumption; WE: work economy; V′E: minute ventilation; V′O2: oxygen uptake; ND: no data. #: n=5; ¶: n=7; +: significance levels between baseline control and baseline COPD; §: significance levels between baseline COPD and follow-up COPD. **: p<0.01; ***: p<0.001 between controls and COPD at follow-up.